Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2004;109:526-531
Published online before print January 19, 2004, doi: 10.1161/01.CIR.0000109700.81266.32
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
109/4/526    most recent
01.CIR.0000109700.81266.32v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tokunaga, N.
Right arrow Articles by Mori, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tokunaga, N.
Right arrow Articles by Mori, H.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Hazardous Substances DB
*GELATIN
Related Collections
Right arrow Angiogenesis

(Circulation. 2004;109:526-531.)
© 2004 American Heart Association, Inc.


Basic Science Reports

Adrenomedullin Gene Transfer Induces Therapeutic Angiogenesis in a Rabbit Model of Chronic Hind Limb Ischemia

Benefits of a Novel Nonviral Vector, Gelatin

Noriyuki Tokunaga, MD; Noritoshi Nagaya, MD; Mikiyasu Shirai, MD; Etsuro Tanaka, MD; Hatsue Ishibashi-Ueda, MD; Mariko Harada-Shiba, MD; Munetake Kanda, MD; Takefumi Ito, MD; Wataru Shimizu, MD; Yasuhiko Tabata, PhD; Masaaki Uematsu, MD; Kazuhiro Nishigami, MD; Shunji Sano, MD; Kenji Kangawa, PhD; Hidezo Mori, MD

From the Department of Cardiac Physiology, National Cardiovascular Center Research Institute, Osaka, Japan (N.T., M.S., M.K., H.M.); the Department of Cardiovascular Surgery, Okayama University Medical School, Okayama, Japan (N.T., S.S.); the Department of Regenerative Medicine and Tissue Engineering, National Cardiovascular Center Research Institute, Osaka, Japan (N.N., T.I.); the Department of Internal Medicine, National Cardiovascular Center, Osaka, Japan (N.N., W.S., K.N.); the Department of Physiology, the Research Center for Genetic Engineering and Cell Transplantation, Tokai University School of Medicine, Isehara, Japan (E.T.); the Department of Pathology, National Cardiovascular Center, Osaka, Japan (H.I.-U.); the Department of Biochemistry, National Cardiovascular Center Research Institute, Osaka, Japan (M.H.-S., K.K.); the Department of Biomaterials, Field of Tissue Engineering, Institute for Frontier Medical Sciences, Kyoto University, Kyoto, Japan (Y.T.); and the Cardiovascular Division, Kansai Rosai Hospital, Hyogo, Japan (M.U.).

Correspondence to Noritoshi Nagaya, MD, Department of Regenerative Medicine and Tissue Engineering or Hidezo Mori, MD, Department of Cardiac Physiology, National Cardiovascular Center Research Institute, 5-7-1 Fujishirodai, Suita, Osaka 565-8565, Japan. E-mail nagayann{at}hsp.ncvc.go.jp or hidemori@ri.ncvc.go.jp

Received May 20, 2003; revision received September 25, 2003; accepted September 26, 2003.

Background— Earlier studies have shown that adrenomedullin (AM), a potent vasodilator peptide, has a variety of cardiovascular effects. However, whether AM has angiogenic potential remains unknown. This study investigated whether AM gene transfer induces therapeutic angiogenesis in chronic hind limb ischemia.

Methods and Results— Ischemia was induced in the hind limb of 21 Japanese White rabbits. Positively charged biodegradable gelatin was used to produce ionically linked DNA-gelatin complexes that could delay DNA degradation. Human AM DNA (naked AM group), AM DNA-gelatin complex (AM-gelatin group), or gelatin alone (control group) was injected into the ischemic thigh muscles. Four weeks after gene transfer, significant improvements in collateral formation and hind limb perfusion were observed in the naked AM group and AM-gelatin group compared with the control group (calf blood pressure ratio: 0.60±0.02, 0.72±0.03, 0.42±0.06, respectively). Interestingly, hind limb perfusion and capillary density of ischemic muscles were highest in the AM-gelatin group, which revealed the highest content of AM in the muscles among the three groups. As a result, necrosis of lower hind limb and thigh muscles was minimal in the AM-gelatin group.

Conclusions— AM gene transfer induced therapeutic angiogenesis in a rabbit model of chronic hind limb ischemia. Furthermore, the use of biodegradable gelatin as a nonviral vector augmented AM expression and thereby enhanced the therapeutic effects of AM gene transfer. Thus, gelatin-mediated AM gene transfer may be a new therapeutic strategy for the treatment of peripheral vascular diseases.


Key Words: peripheral vascular disease • angiogenesis • gene therapy • ischemia




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
D. Jin, K. Harada, S. Ohnishi, K. Yamahara, K. Kangawa, and N. Nagaya
Adrenomedullin induces lymphangiogenesis and ameliorates secondary lymphoedema
Cardiovasc Res, December 1, 2008; 80(3): 339 - 345.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
A R Lyon, M Sato, R J Hajjar, R J Samulski, and S E Harding
Gene therapy: targeting the myocardium
Heart, January 1, 2008; 94(1): 89 - 99.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
B. Yanagawa, M. Kataoka, S. Ohnishi, M. Kodama, K. Tanaka, Y. Miyahara, H. Ishibashi-Ueda, Y. Aizawa, K. Kangawa, and N. Nagaya
Infusion of adrenomedullin improves acute myocarditis via attenuation of myocardial inflammation and edema
Cardiovasc Res, October 1, 2007; 76(1): 110 - 118.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
T. Itoh, H. Obata, S. Murakami, K. Hamada, K. Kangawa, H. Kimura, and N. Nagaya
Adrenomedullin ameliorates lipopolysaccharide-induced acute lung injury in rats
Am J Physiol Lung Cell Mol Physiol, August 1, 2007; 293(2): L446 - L452.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
D. Ribatti, M. T. Conconi, and G. G. Nussdorfer
Nonclassic Endogenous Novel Regulators of Angiogenesis
Pharmacol. Rev., June 1, 2007; 59(2): 185 - 205.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
O. J. Muller, H. A. Katus, and R. Bekeredjian
Targeting the heart with gene therapy-optimized gene delivery methods
Cardiovasc Res, February 1, 2007; 73(3): 453 - 462.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
K. Miyashita, H. Itoh, H. Arai, T. Suganami, N. Sawada, Y. Fukunaga, M. Sone, K. Yamahara, T. Yurugi-Kobayashi, K. Park, et al.
The Neuroprotective and Vasculo-Neuro-Regenerative Roles of Adrenomedullin in Ischemic Brain and Its Therapeutic Potential
Endocrinology, April 1, 2006; 147(4): 1642 - 1653.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
S. Murakami, N. Nagaya, T. Itoh, T. Iwase, T. Fujisato, K. Nishioka, K. Hamada, K. Kangawa, and H. Kimura
Adrenomedullin Regenerates Alveoli and Vasculature in Elastase-induced Pulmonary Emphysema in Mice
Am. J. Respir. Crit. Care Med., September 1, 2005; 172(5): 581 - 589.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
N. Nagaya, K. Kangawa, T. Itoh, T. Iwase, S. Murakami, Y. Miyahara, T. Fujii, M. Uematsu, H. Ohgushi, M. Yamagishi, et al.
Transplantation of Mesenchymal Stem Cells Improves Cardiac Function in a Rat Model of Dilated Cardiomyopathy
Circulation, August 23, 2005; 112(8): 1128 - 1135.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
N. Nagaya, H. Mori, S. Murakami, K. Kangawa, and S. Kitamura
Adrenomedullin: angiogenesis and gene therapy
Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2005; 288(6): R1432 - R1437.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
K. Hanabusa, N. Nagaya, T. Iwase, T. Itoh, S. Murakami, Y. Shimizu, W. Taki, K. Miyatake, and K. Kangawa
Adrenomedullin Enhances Therapeutic Potency of Mesenchymal Stem Cells After Experimental Stroke in Rats
Stroke, April 1, 2005; 36(4): 853 - 858.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
T. Fujii, N. Nagaya, T. Iwase, S. Murakami, Y. Miyahara, K. Nishigami, H. Ishibashi-Ueda, M. Shirai, T. Itoh, K. Ishino, et al.
Adrenomedullin enhances therapeutic potency of bone marrow transplantation for myocardial infarction in rats
Am J Physiol Heart Circ Physiol, March 1, 2005; 288(3): H1444 - H1450.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
T. Iwase, N. Nagaya, T. Fujii, T. Itoh, H. Ishibashi-Ueda, M. Yamagishi, K. Miyatake, T. Matsumoto, S. Kitamura, and K. Kangawa
Adrenomedullin Enhances Angiogenic Potency of Bone Marrow Transplantation in a Rat Model of Hindlimb Ischemia
Circulation, January 25, 2005; 111(3): 356 - 362.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
S. Iimuro, T. Shindo, N. Moriyama, T. Amaki, P. Niu, N. Takeda, H. Iwata, Y. Zhang, A. Ebihara, and R. Nagai
Angiogenic Effects of Adrenomedullin in Ischemia and Tumor Growth
Circ. Res., August 20, 2004; 95(4): 415 - 423.
[Abstract] [Full Text] [PDF]